Navigation Links
Cyclacel Pharmaceuticals to Report Sapacitabine Phase I Study,Results at the American Society of Clinical Oncology Annual Meeting

logo and Cyclacel(R) are trademarks of Cyclacel Pharmaceuticals, Inc.

Risk Factors

This news release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Such forward-looking statements include statements regarding, among other things, the efficacy, safety, and intended utilization of Cyclacel's product candidates, the conduct and results of future clinical trials, plans regarding regulatory filings, future research and clinical trials and plans regarding partnering activities. Factors that may cause actual results to differ materially include the risk that product candidates that appeared promising in early research and clinical trials do not demonstrate safety and/or efficacy in larger-scale or later clinical trials, the risk that Cyclacel will not obtain approval to market its products, the risks associated with reliance on outside financing to meet capital requirements, and the risks associated with reliance on collaborative partners for further clinical trials, development and commercialization of product candidates. You are urged to consider statements that include the words "may," "will," "would," "could," "should," "believes," "estimates," "projects," "potential," "expects," "plans," "anticipates," "intends," "continues," "forecast," "designed," "goal," or the negative of those words or other comparable words to be uncertain and forward-looking. These factors and others are more fully discussed under "Risk Factors" in the registration statement on Forms S-3 (File No. 333-134945) and S-4 (File No. 333-131225) and in the other reports of Cyclacel filed with the SEC.

Contact

For Investors:
TS Communications Group, LLC
Tara Spiess / Andrea Romstad
914-921-5900
or
For Media:
Feinstein Kean Healthcare
H
'"/>




Page: 1 2 3

Related medicine technology :

1. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
2. Cyclacel Pharmaceuticals to Present Preclinical Data on Sapacitabine and Seliciclib at AACR
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
(Date:3/2/2015)... SANTA ANA, Calif. , March 2, 2015 ... premier supplier of child-resistant packaging solutions for ... Co-Founder, Nicholas Kovacevich , has been nominated ... The Excellence in Entrepreneurship Award is ... entrepreneurial spirit – individuals who, by their creativity ...
(Date:3/2/2015)... NEW YORK , March 2, 2015 /PRNewswire/ ... LLC is investigating potential claims on behalf of ... ("Vitae Pharmaceuticals" or the "Company") (NasdaqGM: VTAE -News).  ... Bronstein or his investor relations coordinator ... 212-697-6484. The investigation concerns whether Vitae ...
(Date:3/2/2015)... March 2, 2015  CANTEL MEDICAL CORP. (NYSE: ... Krakauer , CEO, will be presenting at the Sidoti ... The formal presentation is scheduled for 2:00 PM ET ... Hotel, New York . In addition, ... Development, will be available for separate one-on-one meetings during ...
Breaking Medicine Technology:Kush Bottles CEO, Nicholas Kovacevich, Nominated for 2015 "Excellence in Entrepreneurship Award" 2SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Vitae Pharmaceuticals, Inc. 2
... 2011 /PRNewswire-Asia-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN; NYSE: ... previously announced acquisition of BMP Sunstone Corporation (NASDAQ: BJGP). ... Sunstone stockholders approved the adoption of the merger agreement ... wholly owned subsidiary of sanofi-aventis, dated October 28, 2010, ...
... 2011 Delta Health Technologies® LLC ("Delta") ... Therapy Report, detailing the findings from the Delta National ... develop strategies and guidelines to ensure that homecare patients ... the homecare software industry for more than 40 years, ...
Cached Medicine Technology:Sanofi-Aventis Announces Approval and Closing of BMP Sunstone Acquisition Creating a Strong Consumer Health Care Platform in China 2Delta National Excellence in Therapy Report Now Available 2
(Date:3/2/2015)... (PRWEB) March 02, 2015 Doctors in ... be a better predictor of outcomes for people with ... read details of the new study on the ... at the University of Eastern Piedmont followed the cases ... pleurodesis treatment for excess lung fluid. , “Persistent ...
(Date:3/2/2015)... Angeles, CA (PRWEB) March 02, 2015 ... offering gum reshaping procedures. Gum reshaping can involve one or ... or to regenerate lost gum tissue for a more even ... dark gum line treatment that can permanently lighten ... his total smile approach, which involves a personalized treatment plan ...
(Date:3/2/2015)... 02, 2015 After a rigorous evaluation ... service, pricing and long-term strategy, Blood Centers of America ... choice for member centers’ testing needs. , BCA, which ... more than 30 percent of the U.S. blood supply, ... “BCA is committed to drive cost savings to members,” ...
(Date:3/2/2015)... 02, 2015 New York singer/songwriter ... be delivering a plenary address entitled Finding the ... Art of Healing and Recovery at this year’s ... Healthcare Executive Summit (BHES).     , With more than ... have been recorded by some of the biggest ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Over the ... acquisitions among leading vendors seeking to expand their geographic ... market is expected to reach $6.2 billion by 2019 ... North America including the U.S. and Canada and a ... devices. However developing regions such as Asia-Pacific including China ...
Breaking Medicine News(10 mins):Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Gummy Smile Expert, Dr. Alex Farnoosh, is Now Offering Gum Reshaping Procedures 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 3Health News:Richie Supa Announced as a Plenary Speaker at NCAD 2015 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 3
... Steven Reinberg HealthDay Reporter , THURSDAY, April 12 ... partners are having babies than ever before, a new government ... 2010 were to such couples -- a threefold increase from ... Prevention found. "It,s thought that in births outside of ...
... In a study published in Nutrition Research , ... consumption with nutrient intake, diet quality and the prevalence ... in both children and adults. Consumers of OOHN, including ... pine nuts, pistachios and walnuts), had higher intakes of ...
... April 11, 2012 -- In a scientific paper ... researchers from SomaLogic and the University of Washington in ... assay technology to tissue samples. Working with both tumor ... lung cancer (NSCLC), they identified significant expression changes in ...
... , WEDNESDAY, April 11 (HealthDay News) -- The spouses ... and stroke, a new study suggests. Researchers said the ... health of caregivers. Using the national Swedish cancer registry ... heart disease and stroke increased by 13 to 29 percent ...
... , WEDNESDAY, April 11 (HealthDay News) -- Treatment-related ... their therapy has been completed, a new study says. ... and found that more than 60 percent of them ... years after their diagnosis, and 30 percent had at ...
... , WEDNESDAY, April 11 (HealthDay News) -- ... people in the United States who lived in state-regulated ... federal report. People who live in residential care ... supportive services because they can,t live independently but generally ...
Cached Medicine News:Health News:More Unmarried Couples Having Babies: CDC 2Health News:Out-of-hand tree nut consumption associated with better diet quality in children and adults 2Health News:SomaLogic publishes proteomic biomarker analysis of lung cancer tissue samples 2Health News:Breast Cancer Treatment Side Effects May Last for Years 2